These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 32623215)
21. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Brandes AA; Franceschi E; Tosoni A; Benevento F; Scopece L; Mazzocchi V; Bacci A; Agati R; Calbucci F; Ermani M Cancer; 2009 Aug; 115(15):3512-8. PubMed ID: 19514084 [TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of concomitant radiotherapy in newly diagnosed glioblastoma multiforme: a multivariate analysis of 116 patients. Okumus NO; Gursel B; Meydan D; Ozdemir O; Odabas E; Gonullu G Ann Saudi Med; 2012; 32(3):250-5. PubMed ID: 22588435 [TBL] [Abstract][Full Text] [Related]
23. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. Minniti G; De Sanctis V; Muni R; Filippone F; Bozzao A; Valeriani M; Osti MF; De Paula U; Lanzetta G; Tombolini V; Maurizi Enrici R J Neurooncol; 2008 May; 88(1):97-103. PubMed ID: 18250965 [TBL] [Abstract][Full Text] [Related]
24. Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study. Fabbro-Peray P; Zouaoui S; Darlix A; Fabbro M; Pallud J; Rigau V; Mathieu-Daude H; Bessaoud F; Bauchet F; Riondel A; Sorbets E; Charissoux M; Amelot A; Mandonnet E; Figarella-Branger D; Duffau H; Tretarre B; Taillandier L; Bauchet L J Neurooncol; 2019 Mar; 142(1):91-101. PubMed ID: 30523606 [TBL] [Abstract][Full Text] [Related]
25. Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma. Clarke JL; Iwamoto FM; Sul J; Panageas K; Lassman AB; DeAngelis LM; Hormigo A; Nolan CP; Gavrilovic I; Karimi S; Abrey LE J Clin Oncol; 2009 Aug; 27(23):3861-7. PubMed ID: 19506159 [TBL] [Abstract][Full Text] [Related]
26. Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide. Fiorica F; Berretta M; Colosimo C; Stefanelli A; Ursino S; Zanet E; Palmucci T; Maugeri D; Malaguarnera M; Palmucci S; Grasso M; Tirelli U; Cartei F Arch Gerontol Geriatr; 2010; 51(1):31-5. PubMed ID: 19628288 [TBL] [Abstract][Full Text] [Related]
27. Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide. Donato V; Papaleo A; Castrichino A; Banelli E; Giangaspero F; Salvati M; Delfini R Tumori; 2007; 93(3):248-56. PubMed ID: 17679459 [TBL] [Abstract][Full Text] [Related]
28. Temozolomide and radiotherapy as first-line treatment of high-grade gliomas. Corsa P; Parisi S; Raguso A; Troiano M; Perrone A; Cossa S; Munafò T; Piombino M; Spagnoletti G; Borgia F Tumori; 2006; 92(4):299-305. PubMed ID: 17036520 [TBL] [Abstract][Full Text] [Related]
29. MGMT gene silencing and benefit from temozolomide in glioblastoma. Hegi ME; Diserens AC; Gorlia T; Hamou MF; de Tribolet N; Weller M; Kros JM; Hainfellner JA; Mason W; Mariani L; Bromberg JE; Hau P; Mirimanoff RO; Cairncross JG; Janzer RC; Stupp R N Engl J Med; 2005 Mar; 352(10):997-1003. PubMed ID: 15758010 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of concomitant and adjuvant temozolomide in glioblastoma treatment. A multicentre randomized study. Szczepanek D; Marchel A; Moskała M; Krupa M; Kunert P; Trojanowski T Neurol Neurochir Pol; 2013; 47(2):101-8. PubMed ID: 23649997 [TBL] [Abstract][Full Text] [Related]
31. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466). Linz U Cancer; 2010 Apr; 116(8):1844-6. PubMed ID: 20151424 [TBL] [Abstract][Full Text] [Related]
32. Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial. Tesileanu CMS; Sanson M; Wick W; Brandes AA; Clement PM; Erridge SC; Vogelbaum MA; Nowak AK; Baurain JF; Mason WP; Wheeler H; Chinot OL; Gill S; Griffin M; Rogers L; Taal W; Rudà R; Weller M; McBain C; van Linde ME; Aldape K; Jenkins RB; Kros JM; Wesseling P; von Deimling A; Hoogstrate Y; de Heer I; Atmodimedjo PN; Dubbink HJ; Brouwer RWW; van IJcken WFJ; Cheung KJ; Golfinopoulos V; Baumert BG; Gorlia T; French PJ; van den Bent MJ Clin Cancer Res; 2022 Jun; 28(12):2527-2535. PubMed ID: 35275197 [TBL] [Abstract][Full Text] [Related]
33. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma. Hamilton DA Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911 [No Abstract] [Full Text] [Related]
34. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors. Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394 [TBL] [Abstract][Full Text] [Related]
35. Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial. Sandmann T; Bourgon R; Garcia J; Li C; Cloughesy T; Chinot OL; Wick W; Nishikawa R; Mason W; Henriksson R; Saran F; Lai A; Moore N; Kharbanda S; Peale F; Hegde P; Abrey LE; Phillips HS; Bais C J Clin Oncol; 2015 Sep; 33(25):2735-44. PubMed ID: 26124478 [TBL] [Abstract][Full Text] [Related]
36. Temozolomide in glioblastoma multiforme of the elderly. Brandes AA; Vastola F; Basso U; Pasetto LM; Ermani M; Berti F; Rotilio A; Amistà P; Scienza R; Monfardini S Tumori; 2002; 88(1 Suppl 1):S69-70. PubMed ID: 11989929 [No Abstract] [Full Text] [Related]
37. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840 [TBL] [Abstract][Full Text] [Related]
38. Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for the treatment of glioblastoma: a novel prognostic factor for survival. Williams M; Liu ZW; Woolf D; Hargreaves S; Michalarea V; Menashy R; Kooner I; Wilson E J Cancer Res Clin Oncol; 2012 Oct; 138(10):1683-8. PubMed ID: 22644996 [TBL] [Abstract][Full Text] [Related]
39. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience. Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635 [TBL] [Abstract][Full Text] [Related]
40. Going past the data for temozolomide. Villano JL; Letarte N; Bressler LR Cancer Chemother Pharmacol; 2012 Apr; 69(4):1113-5. PubMed ID: 22147076 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]